Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates

Metastatic urothelial cancer, associated with a poor prognosis, is still major cause of cancer-related death, with scarce options of effective treatment after progression to platinum-based chemotherapy and immunotherapy. The human epithelial growth factor receptor 2 (Her-2) has been identified as a...

Full description

Bibliographic Details
Main Authors:	Víctor Albarrán, Diana Isabel Rosero, Jesús Chamorro, Javier Pozas, María San Román, Ana María Barrill, Víctor Alía, Pilar Sotoca, Patricia Guerrero, Juan Carlos Calvo, Inmaculada Orejana, Patricia Pérez de Aguado, Pablo Gajate
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	International Journal of Molecular Sciences
Subjects:	urothelial cancer Her-2 targeted therapy monoclonal antibody tyrosine-kinase inhibitor antibody-drug conjugate
Online Access:	https://www.mdpi.com/1422-0067/23/20/12659

Similar Items

Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer
by: Huizi Lei, et al.
Published: (2023-06-01)

Development of Highly Sensitive Anti-Mouse HER2 Monoclonal Antibodies for Flow Cytometry
by: Tsunenori Ouchida, et al.
Published: (2023-08-01)

Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients
by: Kejia Zhu, et al.
Published: (2024-02-01)

Improving Receptor-Mediated Intracellular Access and Accumulation of Antibody Therapeutics—The Tale of HER2
by: Jeffrey V. Leyton
Published: (2020-07-01)

Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody
by: Jackie Cheng, et al.
Published: (2020-09-01)

Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma
by: Sarah E. Fenton, et al.
Published: (2023-01-01)

Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
by: Elie Rassy, et al.
Published: (2022-12-01)

Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992)

A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models
by: Mika K. Kaneko, et al.
Published: (2024-02-01)

Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995)

Antibody–drug conjugates in urothelial carcinoma: scientometric analysis and clinical trials analysis
by: Meng Zhang, et al.
Published: (2024-03-01)

Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report
by: Amanuel Hassen Ali, et al.
Published: (2023-08-01)

Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy
by: Xiangyun You, et al.
Published: (2024-02-01)

Research progress of antibody-drug conjugates therapy for HER2-low expressing gastric cancer
by: Minghui Yu, et al.
Published: (2023-03-01)

Advances in the progress of monoclonal antibodies for rabies
by: Linlin Fan, et al.
Published: (2022-01-01)

Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy
by: Iqra Fatima, et al.
Published: (2021-12-01)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01)

Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis
by: Wu Lin, et al.
Published: (2023-10-01)

Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
by: Heidi Ko, et al.
Published: (2023-11-01)

Monoclonal antibodies : principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology /
by: 250151 Goding, James W.
Published: (1996)

Monoclonal antibodies in immunoscintigraphy /
by: Chatal, Jean-Francois
Published: (1989)

Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer
by: Mariana K. Najjar, et al.
Published: (2022-11-01)

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
by: Antonio Ungaro, et al.
Published: (2022-02-01)

Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.

HER2 Expression in Peritoneal Dissemination of High-Grade Serous Ovarian Carcinoma: A Comparative Study of Immunohistochemical Reactivity Using Four HER2 Antibodies
by: Min-Kyung Yeo, et al.
Published: (2022-11-01)

Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform
by: Esmaeil Dorraji, et al.
Published: (2022-10-01)

A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines
by: Dixita M. Patel, et al.
Published: (2024-01-01)

Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
by: Leonardo F. Ormundo, et al.
Published: (2023-10-01)

Monoclonal antibodies : methods and protocols /
by: Albitar, Maher
Published: (2007)

PREPARATION AND PROPERTIES OF MURINE ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES RECOGNIZING PRIMARY RABBIT POLYCLONAL ANTIBODIES AGAINST MORPHINE DERIVATIVES
by: A. V. Trofimov, et al.
Published: (2019-12-01)

Commentary: Brief report - Monoclonal antibodies illustrate the difficulties in measuring blocking TSH receptor antibodies
by: Paul D. Olivo, et al.
Published: (2022-10-01)

EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors
by: Emily Capone, et al.
Published: (2021-04-01)

Current trends in monoclonal antibody development and manufacturing /
by: Shire, Steven J.
Published: (2010)

Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma
by: Nami Tateyama, et al.
Published: (2022-11-01)

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
by: Evi B. Struble, et al.
Published: (2023-05-01)

Monoclonal antibodies : a manual of techniques /
by: 186276 Zola, Heddy
Published: (1987)

Monoclonal antibodies against bacteria/
by: Conway de Macario, Everly, et al.
Published: (1985)

Monoclonal War: The Antibody Arsenal and Targets for Expanded Application
by: Eric H. Rosenn, et al.
Published: (2023-09-01)

A Tetravalent Biparatopic Antibody Causes Strong HER2 Internalization and Inhibits Cellular Proliferation
by: Filippo Benedetti, et al.
Published: (2021-10-01)

DB-1310, an ADC comprised of a novel anti-HER3 antibody conjugated to a DNA topoisomerase I inhibitor, is highly effective for the treatment of HER3-positive solid tumors
by: Xi Li, et al.
Published: (2024-04-01)